Lightlab deal brings Goodman imaging technology
This article was originally published in Clinica
Japanese company Goodman has bought Lightlab Imaging, which develops optical coherence technology (OCT), a method that Goodman believes has the potential to dramatically change imaging for improved diagnosis and treatment. Tokyo-based Goodman, which develops and sells interventional vascular devices, says Lightlab will become a wholly owned subsidiary.
You may also be interested in...
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.
In second letter this year targeting email communications, OPDP says that putting the methotrexate oral solution’s risk information below the signature block does not offer ‘prominence and readability’ comparable to the information on the drug’s effectiveness for the treatment of acute lymphoblastic leukemia that was in the body of the email.